{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:24:15Z","timestamp":1791429855804,"version":"4.3.3"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":268,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.clinsp.2025.100805","type":"journal-article","created":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:50:29Z","timestamp":1760237429000},"page":"100805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["\u03b2-glucan combined with PD-1\/PD-L1 checkpoint blockade suppresses pancreatic tumor growth after ablation therapy"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0766-0144","authenticated-orcid":false,"given":"Shengbo","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5344-8023","authenticated-orcid":false,"given":"Xixi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4860-2193","authenticated-orcid":false,"given":"Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0170-8302","authenticated-orcid":false,"given":"Jiayuan","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8960-9167","authenticated-orcid":false,"given":"Bin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clinsp.2025.100805_bib0001","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"23","key":"10.1016\/j.clinsp.2025.100805_bib0002","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1001\/jama.2021.20065","article-title":"A review of pancreatic cancer","volume":"326","author":"Neoptolemos","year":"2021","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10.1016\/j.clinsp.2025.100805_bib0003","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.ijsu.2008.12.028","article-title":"Microwave tumors ablation: principles, clinical applications and review of preliminary experiences","volume":"6","author":"Carrafiello","year":"2008","journal-title":"Int J Surg"},{"issue":"6","key":"10.1016\/j.clinsp.2025.100805_bib0004","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jhep.2010.04.040","article-title":"CD95 is a key mediator of invasion and accelerated outgrowth of mouse colorectal liver metastases following radiofrequency ablation","volume":"53","author":"Nijkamp","year":"2010","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.clinsp.2025.100805_bib0005","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1148\/radiol.2017162943","article-title":"Targeting STAT3 to Suppress Systemic Pro-Oncogenic Effects from Hepatic Radiofrequency Ablation","volume":"286","author":"Kumar","year":"2018","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.clinsp.2025.100805_bib0006","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jhep.2019.01.027","article-title":"Combined locoregional-immunotherapy for liver cancer","volume":"70","author":"Greten","year":"2019","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.clinsp.2025.100805_bib0007","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.ccell.2020.08.004","article-title":"Challenges and opportunities for pancreatic cancer immunotherapy","volume":"38","author":"Bear","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.clinsp.2025.100805_bib0008","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.iy.04.040186.002101","article-title":"Current status of immunological adjuvants","volume":"4","author":"Warren","year":"1986","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.clinsp.2025.100805_bib0009","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijbiomac.2021.02.207","article-title":"Antitumor effect of soluble beta-glucan as an immune stimulant","volume":"179","author":"Wu","year":"2021","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100805_bib0010","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/cei\/uxad080","article-title":"Yeast beta-glucan modulates macrophages and improves antitumor NK-cell responses in cancer","volume":"214","author":"Zhu","year":"2023","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100805_bib0011","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41467-022-28407-4","article-title":"The induction of peripheral trained immunity in the pancreas incites anti-tumor activity to control pancreatic cancer progression","volume":"13","author":"Geller","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.clinsp.2025.100805_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.116715","article-title":"Beta-1,6 glucan converts tumor-associated macrophages into an M1-like phenotype","volume":"247","author":"Cheng","year":"2020","journal-title":"Carbohydr Polym"},{"issue":"21","key":"10.1016\/j.clinsp.2025.100805_bib0013","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1158\/1078-0432.CCR-10-0820","article-title":"Orally administered particulate beta-glucan modulates tumor-capturing dendritic cells and improves antitumor T-cell responses in cancer","volume":"16","author":"Li","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"6284","key":"10.1016\/j.clinsp.2025.100805_bib0014","doi-asserted-by":"crossref","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: a program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.clinsp.2025.100805_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108387","article-title":"BCG Vaccination Induces Long-Term Functional Reprogramming of Human Neutrophils","volume":"33","author":"Moorlag","year":"2020","journal-title":"Cell Rep"},{"issue":"6204","key":"10.1016\/j.clinsp.2025.100805_bib0016","doi-asserted-by":"crossref","DOI":"10.1126\/science.1251086","article-title":"Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity","volume":"345","author":"Saeed","year":"2014","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100805_bib0017","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"7","key":"10.1016\/j.clinsp.2025.100805_bib0018","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrmicro1681","article-title":"The perfect mix: recent progress in adjuvant research","volume":"5","author":"Guy","year":"2007","journal-title":"Nat Rev Microbiol"},{"issue":"6290","key":"10.1016\/j.clinsp.2025.100805_bib0019","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1126\/science.aaf3036","article-title":"An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells","volume":"352","author":"Zanoni","year":"2016","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.clinsp.2025.100805_bib0020","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000355628","article-title":"Long-lasting effects of BCG vaccination on both heterologous Th1\/Th17 responses and innate trained immunity","volume":"6","author":"Kleinnijenhuis","year":"2014","journal-title":"J Innate Immun"},{"issue":"49","key":"10.1016\/j.clinsp.2025.100805_bib0021","doi-asserted-by":"crossref","first-page":"54399","DOI":"10.1021\/acsami.0c15522","article-title":"Employing ATP as a new adjuvant promotes the induction of robust antitumor cellular immunity by a PLGA nanoparticle vaccine","volume":"12","author":"Zhang","year":"2020","journal-title":"ACS Appl Mater Interfaces (Providence)"},{"issue":"28","key":"10.1016\/j.clinsp.2025.100805_bib0022","doi-asserted-by":"crossref","first-page":"32703","DOI":"10.1021\/acsami.1c06701","article-title":"Development of drug-resistant klebsiella pneumoniae vaccine via novel vesicle production technology","volume":"13","author":"Li","year":"2021","journal-title":"ACS Appl Mater Interfaces (Providence)"},{"issue":"2","key":"10.1016\/j.clinsp.2025.100805_bib0023","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.chom.2012.06.006","article-title":"Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes","volume":"12","author":"Quintin","year":"2012","journal-title":"Cell Host Microbe"},{"issue":"6204","key":"10.1016\/j.clinsp.2025.100805_bib0024","doi-asserted-by":"crossref","DOI":"10.1126\/science.1250684","article-title":"mTOR- and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity","volume":"345","author":"Cheng","year":"2014","journal-title":"Science"},{"issue":"33","key":"10.1016\/j.clinsp.2025.100805_bib0025","doi-asserted-by":"crossref","first-page":"15677","DOI":"10.1039\/C8NR03927E","article-title":"Mitochondria-targeting nanoparticles for enhanced microwave ablation of cancer","volume":"10","author":"Chen","year":"2018","journal-title":"Nanoscale"},{"issue":"10","key":"10.1016\/j.clinsp.2025.100805_bib0026","article-title":"Local release of TGF-beta inhibitor modulates tumor-associated neutrophils and enhances pancreatic cancer response to combined irreversible electroporation and immunotherapy","volume":"9","author":"Peng","year":"2022","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100805_bib0027","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1038\/s41467-019-13204-3","article-title":"Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy","volume":"10","author":"Shi","year":"2019","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.clinsp.2025.100805_bib0028","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/hep.1840080511","article-title":"Activation of murine Kupffer cell tumoricidal activity by liposomes containing lipophilic muramyl dipeptide","volume":"8","author":"Phillips","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.clinsp.2025.100805_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.598877","article-title":"Augmenting anticancer immunity through combined targeting of angiogenic and PD-1\/PD-L1 pathways: challenges and opportunities","volume":"11","author":"Hack","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.clinsp.2025.100805_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinsp.2023.100177","article-title":"Programmed cell death-1 and its ligands: current knowledge and possibilities in immunotherapy","volume":"78","author":"Gutic","year":"2023","journal-title":"Clinics (S\u00e3o Paulo)"},{"issue":"4","key":"10.1016\/j.clinsp.2025.100805_bib0031","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.clinsp.2025.100805_bib0032","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ccell.2020.03.017","article-title":"Acquired resistance to immune checkpoint inhibitors","volume":"37","author":"Schoenfeld","year":"2020","journal-title":"Cancer Cell"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593225002236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593225002236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:04:13Z","timestamp":1790712253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593225002236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":32,"alternative-id":["S1807593225002236"],"URL":"https:\/\/doi.org\/10.1016\/j.clinsp.2025.100805","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b2-glucan combined with PD-1\/PD-L1 checkpoint blockade suppresses pancreatic tumor growth after ablation therapy","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinsp.2025.100805","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 HCFMUSP. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100805"}}